FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986282029> ?p ?o ?g. }

• W1986282029 endingPage "5920" @default.
• W1986282029 startingPage "5909" @default.
• W1986282029 abstract "It has been previously reported that appropriately substituted 4-anilinoquinoline-3-carbonitriles are potent inhibitors of Src kinase, with biological activity in vitro and in vivo. Structural modifications to these compounds have been explored, providing the 4-anilinobenzo[g]quinoline-3-carbonitriles as a series with enhanced Src inhibitory properties. The synthesis and structure−activity relationships of these 4-anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles are presented here. Analogues with cyclic basic amine groups attached via ethoxy linkages at the C-8 position were the most active in vitro, with subnanomolar IC50 values against Src kinase observed for a majority of the compounds synthesized. Compound 17d was more potent in vitro than the analogously substituted 4-anilinoquinoline-3-carbonitrile SKI-606, which is undergoing evaluation in clinical trials. The most potent analogue synthesized was 17a, with an IC50 of 0.15 nM against Src kinase and with an IC50 of 10 nM against Src-transformed fibroblasts. Molecular modeling studies provided a rationale for the exceptional activity observed for these compounds, with favorable van der Waals interactions playing the major role. Compound 17c was found to be highly selective for Src kinase when tested against a panel of other kinases, with modest selectivity versus the Src family kinases Lyn and Fyn. Following ip dosing at 50 mg/kg, analogues 17c and 17d were shown to have plasma levels that significantly exceeded the cellular IC50 values against Src-transformed fibroblasts. In an Src-transformed fibroblast xenograft model, both compounds exhibited a significant inhibition of tumor growth." @default.
• W1986282029 created "2016-06-24" @default.
• W1986282029 creator A5008546312 @default.
• W1986282029 creator A5011123989 @default.
• W1986282029 creator A5015056019 @default.
• W1986282029 creator A5022368541 @default.
• W1986282029 creator A5035064577 @default.
• W1986282029 creator A5036135682 @default.
• W1986282029 creator A5039541815 @default.
• W1986282029 creator A5062048801 @default.
• W1986282029 creator A5073401771 @default.
• W1986282029 creator A5080525415 @default.
• W1986282029 creator A5090979481 @default.
• W1986282029 date "2005-08-25" @default.
• W1986282029 modified "2023-10-16" @default.
• W1986282029 title "4-Anilino-7,8-dialkoxybenzo[<i>g</i>]quinoline-3-carbonitriles as Potent Src Kinase Inhibitors" @default.
• W1986282029 cites W1514513302 @default.
• W1986282029 cites W1964399042 @default.
• W1986282029 cites W1969294644 @default.
• W1986282029 cites W1976999762 @default.
• W1986282029 cites W1980292635 @default.
• W1986282029 cites W1996540171 @default.
• W1986282029 cites W2007765297 @default.
• W1986282029 cites W2026415908 @default.
• W1986282029 cites W2030413647 @default.
• W1986282029 cites W2047656505 @default.
• W1986282029 cites W2048814899 @default.
• W1986282029 cites W2058661551 @default.
• W1986282029 cites W2062420449 @default.
• W1986282029 cites W2090895449 @default.
• W1986282029 cites W2101257013 @default.
• W1986282029 cites W2178031032 @default.
• W1986282029 cites W2950703100 @default.
• W1986282029 cites W2951429406 @default.
• W1986282029 cites W2951555034 @default.
• W1986282029 doi "https://doi.org/10.1021/jm050512u" @default.
• W1986282029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16161995" @default.
• W1986282029 hasPublicationYear "2005" @default.
• W1986282029 type Work @default.
• W1986282029 sameAs 1986282029 @default.
• W1986282029 citedByCount "16" @default.
• W1986282029 countsByYear W19862820292013 @default.
• W1986282029 countsByYear W19862820292015 @default.
• W1986282029 countsByYear W19862820292017 @default.
• W1986282029 countsByYear W19862820292018 @default.
• W1986282029 countsByYear W19862820292019 @default.
• W1986282029 countsByYear W19862820292022 @default.
• W1986282029 crossrefType "journal-article" @default.
• W1986282029 hasAuthorship W1986282029A5008546312 @default.
• W1986282029 hasAuthorship W1986282029A5011123989 @default.
• W1986282029 hasAuthorship W1986282029A5015056019 @default.
• W1986282029 hasAuthorship W1986282029A5022368541 @default.
• W1986282029 hasAuthorship W1986282029A5035064577 @default.
• W1986282029 hasAuthorship W1986282029A5036135682 @default.
• W1986282029 hasAuthorship W1986282029A5039541815 @default.
• W1986282029 hasAuthorship W1986282029A5062048801 @default.
• W1986282029 hasAuthorship W1986282029A5073401771 @default.
• W1986282029 hasAuthorship W1986282029A5080525415 @default.
• W1986282029 hasAuthorship W1986282029A5090979481 @default.
• W1986282029 hasConcept C108636557 @default.
• W1986282029 hasConcept C175818844 @default.
• W1986282029 hasConcept C178790620 @default.
• W1986282029 hasConcept C183141693 @default.
• W1986282029 hasConcept C184235292 @default.
• W1986282029 hasConcept C185592680 @default.
• W1986282029 hasConcept C193042331 @default.
• W1986282029 hasConcept C196347352 @default.
• W1986282029 hasConcept C202751555 @default.
• W1986282029 hasConcept C2776309666 @default.
• W1986282029 hasConcept C2777752497 @default.
• W1986282029 hasConcept C2779536868 @default.
• W1986282029 hasConcept C37686147 @default.
• W1986282029 hasConcept C42362537 @default.
• W1986282029 hasConcept C55493867 @default.
• W1986282029 hasConcept C62478195 @default.
• W1986282029 hasConcept C71240020 @default.
• W1986282029 hasConceptScore W1986282029C108636557 @default.
• W1986282029 hasConceptScore W1986282029C175818844 @default.
• W1986282029 hasConceptScore W1986282029C178790620 @default.
• W1986282029 hasConceptScore W1986282029C183141693 @default.
• W1986282029 hasConceptScore W1986282029C184235292 @default.
• W1986282029 hasConceptScore W1986282029C185592680 @default.
• W1986282029 hasConceptScore W1986282029C193042331 @default.
• W1986282029 hasConceptScore W1986282029C196347352 @default.
• W1986282029 hasConceptScore W1986282029C202751555 @default.
• W1986282029 hasConceptScore W1986282029C2776309666 @default.
• W1986282029 hasConceptScore W1986282029C2777752497 @default.
• W1986282029 hasConceptScore W1986282029C2779536868 @default.
• W1986282029 hasConceptScore W1986282029C37686147 @default.
• W1986282029 hasConceptScore W1986282029C42362537 @default.
• W1986282029 hasConceptScore W1986282029C55493867 @default.
• W1986282029 hasConceptScore W1986282029C62478195 @default.
• W1986282029 hasConceptScore W1986282029C71240020 @default.
• W1986282029 hasIssue "19" @default.
• W1986282029 hasLocation W19862820291 @default.
• W1986282029 hasLocation W19862820292 @default.
• W1986282029 hasOpenAccess W1986282029 @default.
• W1986282029 hasPrimaryLocation W19862820291 @default.

• next